Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond

  • J Med Chem. 2025 May 22;68(10):9831-9835. doi: 10.1021/acs.jmedchem.5c01156.
Saghir Ali  1 ,  Xiaochen Tian  1 ,  Kathryn A Cunningham  1 ,  Jia Zhou  1
Affiliations
  • 1. Department of Pharmacology and Toxicology, and Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, Texas 77555, United States.
PMID: 40400369 DOI: 10.1021/acs.jmedchem.5c01156
Products